Biaffin

Newsletter

kinases protein kinase inhibitors signaling activators kinase substrates antibodies bioluminescence assays
Recombinant Human GUCY2C / Guanylyl cyclase C Protein, Fc Tag, 100 µg  

Recombinant Human GUCY2C / Guanylyl cyclase C Protein, Fc Tag, 100 µg

Recombinant Human GUCY2C / Guanylyl cyclase C Protein, AA Ser 24 - Gln 430, expressed from human 293 cells, Fc Tag (MALS verified)

Synonym: Recombinant GUCY2C, GUC2C, STAR, STA receptor, hSTAR, GC-C

More details

GUC-H5257-100

Availability: within 7 days

481,00 €

Background
GUCY2C (Guanylyl Cyclase C), also known as heat-stable enterotoxin receptor, is a type I transmembrane protein of the guanylate cyclase (gc) family that signal by producing cGMP. Guanylate cyclase C (GUCY2C) and its hormones guanylin and uroguanylin have recently emerged as one paracrine axis defending intestinal mucosal integrity against mutational, chemical, and inflammatory injury. GUCY2C murine CAR-T cells recognized and killed human colorectal cancer cells endogenously expressing GUCY2C. Thus, we have identified a human GUCY2C-specific CAR-T cell therapy approach that may be developed for the treatment of GUCY2C-expressing metastatic colorectal cancer.

Source
Recombinant Human GUCY2C, Fc Tag (GUC-H5257) is expressed from human 293 cells (HEK293). It contains AA Ser 24 - Gln 430 (Accession # P25092-1).
Predicted N-terminus: Ser 24

Molecular Characterization
This protein carries a human IgG1 Fc tag at the C-terminus.
The protein has a calculated MW of 72.5 kDa. The protein migrates as 80-130 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

Endotoxin
Less than 0.1 EU per μg by the LAL method.

Purity
>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.

Formulation
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.

Bioactivity
Please refer to product data sheet.

Clinical and Translational Updates

(1) "cGMP-dependent kinase 2, Na+/H+ exchanger NHE3, and PDZ-adaptor NHERF2 co-assemble in apical membrane microdomains"
Luo, Liu, Nikolovska et al
Acta Physiol (Oxf) (2024)
(2) "Clinical course and therapeutic trial for a case of congenital secretory diarrhea due to novel GUCY2C variant"
Scott, Wong, Cramer et al
Am J Med Genet A (2024) 194 (4), e63489
(3) "Fundamental Neurochemistry Review: The role of enteroendocrine cells in visceral pain"
Londregan, Alexander, Covarrubias et al
J Neurochem (2023) 167 (6), 719-732
Showing 1-3 of 148 papers.